| Particulars |
|
|
|
| Company Name
| Sanofi India Ltd
| Year End
| 202412
|
| Full Year |
| Equity (₹ Cr.) |
23.03 |
B.V. (₹) |
339.60 |
| Sales(₹ Cr.) |
2,013.20 |
NP (₹ Cr.) |
442.27 |
| NP Var% |
-25.00 |
Div% |
1,170.00 |
| CPS(₹) |
208.00 |
EPS (₹) |
192.00 |
| Traded Value(₹ Lakhs) |
88.02 |
52 Week High |
6,807.00 |
| 52 Week Low |
4,146.00 |
Price BSE |
4,784.00 |
| Price NSE |
4,783.00 |
Market Capital (₹ Cr.) |
11,018.59 |
| P/C Ratio |
23.00 |
P/E Ratio |
24.90 |
| Price Vs.BV |
14.09 |
|
| Latest Quarter |
| Year End |
202509 |
Sales (₹ Cr.) |
475.40 |
| NP(₹ Cr.) |
94.97 |
NP Var % |
16.00 |
| Trailing Twelve Months |
| Year End |
202509 |
Sales |
2,192.20 |
| OPM |
24.34 |
NP |
421.55 |
| NP Var% |
4.45 |
EPS |
160.35 |
| PE |
29.84 |
|
|